medline.ch Onkologie Urologische Tumoren

	Role of Targeted Therapy in the Management of von Hippel-Lindau Disease-Associated Renal Cell Carcinoma: A Single-Proportion Meta-Analysis. Cureus Abimbola A, Ayeni A, Olaleye A, Banerjee A, Dhanasekaran A. PMID: 41458689 [PubMed]
	Non-systemic treatment of metastatic kidney cancer: systematic review and a case report. Front Oncol Morkunaite GO, Mickeviciute U, Trakymas M, Kincius M, Urbonas V, Kvederas G, Patasius A. PMID: 41458613 [PubMed]
	Prognostic value of platelet to lymphocyte ratio in patients with castration-resistant prostate cancer: a systematic review and meta-analysis. Front Oncol Ying J, Zhou C, Jin Y. PMID: 41458591 [PubMed]
	Chronological Trends of PSA Levels at Diagnosis in Population-based Prostate Cancer Data 2004-2021, a Time Period of Drastic Changes in Screening Guidelines: Potential Implications in Prostate Cancer Diagnosis. J Registry Manag Kato I, Bosland MC, Kim S, Gann PH. PMID: 41458220 [PubMed - indexed for MEDLINE]
	Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) and Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) for Biochemical Recurrence After Radical Prostatectomy. Med Sci Monit Wang H, Huang C. PMID: 41457503 [PubMed - indexed for MEDLINE]
	Impact of the Area Deprivation Index on stage at diagnosis in penile squamous cell carcinoma: A statewide cohort analysis. Cancer Silvani C, Tylecki A, Santangelo A, Stephens A, Considine J, Gishto R, Perry M, Nazzani S, Briganti A, Salonia A, Montorsi F, Nicolai N, Montanari E, Rogers C, Abdollah F. PMID: 41457426 [PubMed - indexed for MEDLINE]
	The Emerging Role of B Cells and Tertiary Lymphoid Structures in Bladder Cancer. Curr Urol Rep Penunuri A, Greenberg E, Phillips J, Katims AB. PMID: 41457151 [PubMed - indexed for MEDLINE]
	Reply to Salvatore Cozzi and Thomas Zilli's, and Alexander Ho and Sean Sachdev's Letters to the Editor re: Markus Graefen, Fabian Falkenbach, Tobias Maurer, et al. Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.09.4144. Eur Urol Falkenbach F, Beyer B, Graefen M. PMID: 41456981 [PubMed - as supplied by publisher]
	Assessing and Predicting Cutaneous Leiomyoma Severity in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome: An Observational Study. J Am Acad Dermatol Udupa M, Ouchene L, Bendayan E, Mija LA, Alamari A, Marino TC, Rahme E, Kaouache M, Foulkes WD, Netchiporouk E. PMID: 41456797 [PubMed - as supplied by publisher]
	Targeted therapies for urothelial carcinoma: From FGFR inhibitors to nextâ€‘generation antibody-drug conjugates (Review). Int J Oncol Du J, Shen H, Zeng T, Liu W, Xie Y. PMID: 41456439 [PubMed - indexed for MEDLINE]
	A Deep Learning-Based Multimodal Clinico-Histology-Genomic Prognostic Model in Prostate Cancer. Ann Surg Oncol Wu X, Zhou M, Zheng B, Lv S, Wei Q. PMID: 41456225 [PubMed - as supplied by publisher]
	Serum PSA levels fluctuations in patients with non-muscle-invasive bladder cancer (NMIBC) undergoing BCG therapy: a prospective study. BMC Urol Ahmadi SP, Sadabadi F, Khoshbin B, Sheikhi Z. PMID: 41455940 [PubMed - as supplied by publisher]
	Etiologic fraction of HPV-attributed anal and penile squamous cell carcinoma: study in specialized hospitals, Sri Lanka. BMC Infect Dis Amarasena WDJK, Goonewardena S, Wijeratne KDBM, Silva V, Gamage D. PMID: 41455902 [PubMed - as supplied by publisher]
	Socioeconomic Status and Prostate-specific Antigen Testing: A Population-based Cohort Study Comparing Organised and Opportunistic Prostate Cancer Testing. Eur Urol Focus Arvendell M, Abbadi A, Phillips L, Crippa A, Nordström T, Lantz A. PMID: 41455654 [PubMed - as supplied by publisher]
	Diagnosis era-stratified analysis is important in the estimation of the risk of second primary cancer following renal cell carcinoma: reply to letter to the editor. Int Urol Nephrol Tundealao S, Okunlola P, Titiloye T, Mayungbo B, Adegbesan A, Sajja A, Olarewaju O. PMID: 41455067 [PubMed - as supplied by publisher]
	Explainable machine learning predicts overall survival in female bladder cancer patients after radical cystectomy. Discov Oncol Zhong MY, Zou XC, Chen PH. PMID: 41455036 [PubMed - as supplied by publisher]
	Post-HIFU surveillance of localized prostate cancer: role of PSMA-PET imaging versus the standard PSA-mpMRI protocol. World J Urol Mercier J, Bento L, Cassou-Mounat T, Prudhomme T, Lagarde S, Game X, Soulie M, Thoulouzan M, Bajeot AS, Roumiguie M. PMID: 41454965 [PubMed - indexed for MEDLINE]
	Application of computed diffusion-weighted imaging in vesical imaging reporting and data system assessment for bladder cancer. Abdom Radiol (NY) Zhang M, Chen C, Zeng X, Zhao Q, Cai W, Ma Z. PMID: 41454947 [PubMed - as supplied by publisher]
	Radical prostatectomy outcomes in patients with PI-RADS 5 lesions and favorable prostate cancer. World J Urol Charvet AL, Long Depaquit T, Bened H, Toledano H, Chemouni D, Daniel L, Bastide C, Baboudjian M. PMID: 41454938 [PubMed - indexed for MEDLINE]
	Global and local information-based prostate image registration of prostate-specific membrane antigen PET/CT and enhanced MRI. Med Phys Niu Y, Ma Z, Zhao H, Deng X, Xu D, Zou W. PMID: 41454834 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 174838

Seite 1 von 8742

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung